RxDoctor Payments Data

Adam Jacobson, MD

Otolaryngology · New York, NYNPI 1265545792

Payments from drug & device makers

$3,271in general payments, 2019–2025

Across 38 payments — averaging $86.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kls-martin L.p.$1K
  • Medical Microinstruments, Inc.$605
  • Davol Inc.$554
  • Axogen$514
  • Medical Device Business Services, Inc.$177
  • Integra Lifesciences Corporation$70
  • plus $272 from 7 others

What the payments were for

  • Travel & lodging$1,47145%
  • Food & beverage$1,78355%
  • Entertainment$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Kls-martin L.p.8$1,080
Medical Microinstruments, Inc.3$605
Davol Inc.4$554
Axogen9$514
Medical Device Business Services, Inc.5$177
Integra Lifesciences Corporation1$70
GSK1$58
Ambu Inc.2$52
Kerecis Limited1$44
Johnson & Johnson1$42
Atos Medical Inc1$32
Cook Medical LLC1$27
Smith+Nephew1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,271 in reported general payments places this provider in the 70th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$191,642
Medicare patients
225
Services billed
595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →